结论：肝结核缺乏特异性表现。
Conclusion: There was no specificity of hepatic tuberculosis.
目的探讨肝结核瘤的诊断与外科治疗措施。
Objective To explore the appropriate diagnosis and treatment for hepatic tuberculoma.
目的探讨二维及彩色多普勒超声在肝结核中的诊断价值。
Objective To investigate the value of two-dimensional and color Doppler ultrasonography in diagnosing hepatic tuberculosis.
方法对经手术与病理证实的肝结核患者的临床资料进行回顾分析。
Methods The pathological and clinical data of hepatic tuberculosis confirmed by operation and pathology were analyzed retrospectively.
目的分析肝结核瘤的MRI表现，探讨MRI在诊断和鉴别诊断中的价值。
Objective to analyze MRI features of hepatic tuberculomas, to evaluate MRI in its diagnosis and differentiation.
结果根据声像图表现，肝结核可分为三型：弥漫型（8例） ，实性团块型（8例） ，脓肿型（2例）。
Results The ultrasonographic features were divided into three types: diffusive type (8 cases), solid lesion type (8 cases), and abscess type (2 cases).
目的探讨吸烟对抗结核药物性肝损的影响。
Objective To study the impact of smoking on hypohepatia caused by anti tuberculosis drugs.
目的：研究氧氟沙星联用抗结核药的肝毒性并探讨其机制。
Objective: to study hepatic toxic injury induced by ofloxacin with Antituberculosis drugs in mice.
前言：目的：探讨n乙酰基转移酶(NAT2)基因型与异烟肼、利福平治疗肺结核致肝毒性的相关性。
Objective: to investigate the relationship between the susceptibility of isoniazid and rifampicin-induced hepatotoxicity and the N-acetyltransferase 2 (NAT2) genotype in the tuberculosis patients.
目的：观察硫普罗宁对合并乙型肝炎的肺结核患者在抗痨治疗时的保肝作用。
Objective: To study the liver protective effect of tiopronin in treatment of pulmonary tuberculosis patients with hepatitis b.
目的分析肝脾结核CT表现，以探讨其诊断和鉴别诊断要点。
Objective To analyze CT findings of hepatospleeno tuberculosis and to explore the characteristics for diagnosis and differential diagnosis of the disease.
肝肉芽肿多由肉样瘤病及结核病引起。
Hepatic granulomas most commonly due to sarcoidosis and tuberculosis.
目的了解抗结核药致肝损害危险因素，为结核病合理化疗提供依据。
Objective to understand risk factors of hepatic toxicity of antituberculosis agents and provide scientific basis for tuberculosis chemotherapy.
腹部淋巴结结核常优势地累及肠系膜（73.7%）、门腔间隙（63.2%）、肝十二指肠韧带（57.9%）、肝胃韧带（47.4%）和腹主动脉周围上部淋巴结（47.4%）。
Tuberculosis commonly involved the lymph nodes in the mesentery(73.7%), portacaval space(63.2%), hepatoduodenal ligament(57.9%), hepatogastric ligament (47.4%) and upper para-aortic region (47.4%).
结论既往肝炎病史、糖尿病史、乙肝病毒标志物阳性、年龄60岁以上、酒精依赖等是抗结核药致肝损害危险因素。
Conclusion Hepatitis history, diabetic, HBV positive marker, alcoholic dependence or age above 60 years is risk factors of hepatic toxicity of antituberculosis agents.
结论复方甘草酸苷用于耐多药肺结核肝功能损害患者保肝疗效可靠，不良反应少。
CONCLUSION: Compound glycyrrhizin has a reliable hepatoprotective efficacy and few adverse drug reactions in treating MDR-TB patients complicating with lesion of liver function.
以上两组资料均不包含贫血、肝肾功能异常、心脑血管疾病、糖尿病、结核病及年老无法耐受手术患者。
The patients involved did not suffered from anemia, liver and renal function disfunction, heart and cerebrovascular disease, diabetes and TB.
目的了解抗结核药物引起肺结核患者的肝损害。
Aim To investigate the liver damages caused by antituberculosis drugs.
方法对58例抗结核药物所致肝损害患者的临床表现及用药前后的肝功能改变情况进行分析。
Methods To analyze the clinical manifestation and change of liver function after taking antituberculosis medicine in 58 patients with tuberculosis.
目的观察还原型谷胱甘肽对抗结核药物所致肝损害是否具有保护作用。
Objective To explore the character of drugs -induced hepatic injury caused by anti-tuberculosis drugs for pulmonary tuberculosis in elderly patients.
结论：复方甘草酸苷联合还原型谷胱甘肽对于抗结核药引起的药物性肝炎具有较好的降酶保肝作用。
Conclusion: Treatment with compound glycyrrhizin and reduced glutathione for anti-TB drug-induced hepatitis has good effects on reducing enzymes and protecting liver.
比较环丙沙星或氧氟沙星联用抗结核药的肝毒性。
To compare hepatic toxic injury induced by concomitant use of ciproxacin or ofloxacin and isoniazid and rifampicin in mice.
目标研究讨论肝外胆管结核的内镜下医治价值。
Objective to discuss the endoscopic therapy of the extrahepatic bile duct stone disease.
目标研究讨论肝外胆管结核的内镜下医治价值。
Objective to discuss the endoscopic therapy of the extrahepatic bile duct stone disease.
应用推荐